AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32381018
Drug: Taxane (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxane (docetaxel 75 mg/m2 on day 1 or paclitaxel 80 mg/m2 on days 1, 8, and 15) with Tmab (8 mg/kg then 6 mg/kg) and Pmab (840 mg then 420 mg) on day 1 of each 21-day cycle
Trial: 34180407
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with pulsed ultrasound and IF current (CTPI)
Trial: 36421046
Drug: Dexamethasone 0.5
RxNorm normalized name: dexamethasone 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.5 mg
Trial: 35322672
Drug: GALACTIC-HF–ineligible cohort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GALACTIC-HF–ineligible cohort not taking guideline-directed medical therapy (GDMT)
Trial: 33819614
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid (ICS) treatment
Trial: 35705334
Drug: Antiarrhythmic drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic drugs (AADs) with risk factor modification (RFM)
Trial: 34895712
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (NS) (10 mL)
Trial: 36069803
Drug: Ibuprofen (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (2 × 600‐mg doses)
Trial: 34894070
Drug: High-dose prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisolone (1 mg/kg/d)
Trial: 32811531
Drug: hUC-MSC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hUC-MSC treatment group
Trial: 33793299
Drug: Palbociclib 125
RxNorm normalized name: palbociclib 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palbociclib 125 mg once daily for 13 cycles in addition to endocrine therapy (ET)
Trial: 33793299
Drug: Placebo for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo for 13 cycles in addition to endocrine therapy (ET)
Trial: 33125702
Drug: Oral tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tranexamic acid
Trial: 32520418
Drug: Active Beet+GFJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Beet+GFJ (250 mL grapefruit juice + 70 mL beetroot juice)
Trial: 32520418
Drug: Active Beet+H2O
RxNorm normalized name: BEET
DrugBank: Beet (DB10640)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active Beet+H2O (250 mL water + 70 mL beetroot juice)
Trial: 34593015
Drug: Therapist-supported internet-delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist-supported internet-delivered behaviour therapy (BIP TIC) for 10-12 weeks
Trial: 35774045
Drug: CLS02021 cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLS02021 cream
Trial: 33711654
Drug: Placebo (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (40 μg d3‐vitamin)
Trial: 35579642
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone (initially 0.6-0.8 mg/kg/d, maximum 48 mg/d, weaning by 8 mg/d/mo)
Trial: 35579642
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone (reduced dose 0.4 mg/kg/d, maximum 32 mg/d, weaning by 4 mg/d/mo)
Trial: 34300310
Drug: Dexmedetomidine (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (0.4 µg/kg/h)
Trial: 33630408
Drug: Nitrate supplementation
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate supplementation (300 mg potassium nitrate/day)
Trial: 33630408
Drug: Placebo (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (300 mg potassium chloride/day)
Trial: 33129278
Drug: Free medications
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free medications
Trial: 35025817
Drug: Evolocumab 420
RxNorm normalized name: evolocumab 420 in 3.5 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evolocumab 420 mg monthly subcutaneous injection
Trial: 33360163
Drug: MS-222 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS-222 at 300 mg/L
Trial: 33360163
Drug: MS-222 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS-222 at 100 mg/L
Trial: 33237254
Drug: #Tamojunto school‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: #Tamojunto school‐based drug prevention program
Trial: 33930187
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter with 500 ml weight attached
Trial: 35169169
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline solution (placebo)
Trial: 32048365
Drug: Saffron supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron supplement (100 mg/day)
Trial: 36125279
Drug: Lasmiditan 200
RxNorm normalized name: lasmiditan 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lasmiditan 200 mg
Trial: 32093628
Drug: Lasmiditan 100
RxNorm normalized name: lasmiditan 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lasmiditan 100 mg and 200 mg
Trial: 34059274
Drug: 1.5% dipotassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5% dipotassium oxalate monohydrate (KOX) oral rinse
Trial: 39236780
Drug: Lactate infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate infusion
Trial: 35064823
Drug: Prophylactic long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic long-acting G-CSF
Trial: 35064823
Drug: Prophylactic standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic standard G-CSF
Trial: 35732385
Drug: Intramuscular midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular midazolam (0.05 mg/kg)
Trial: 35732385
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline 0.01 mL/kg)
Trial: 33121474
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol (10 ml propofol with 1 ml 2% lidocaine), 0.5‐1 mg/kg before endotracheal suctioning
Trial: 32627619
Drug: Transoral CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transoral CO2 laser therapy
Trial: 33218508
Drug: Pilates Matwork
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates Matwork exercises (50 min, twice a week for 4 months)
Trial: 33977744
Drug: Above-knee lateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Above-knee lateral approach (Group L)
Trial: 34535300
Drug: Fixed dose
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dose of 1000 IU of 4F-PCC
Trial: 34535300
Drug: Variable dosing
RxNorm normalized name: methohexital
DrugBank: Methohexital (DB00474)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Variable dosing of 4F-PCC
Trial: 36092193
Drug: Bacillus clausii
RxNorm normalized name: BACILLUS CLAUSII
DrugBank: Bacillus clausii (DB16537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus clausii (Strains O/C, N/R, SIN and T) suspension available as Enterogermina® at the dose of 2 billion spores/5 ml twice daily for 8 weeks along with conventional treatment.
Trial: 36092193
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment only.
Trial: 36092193
Drug: Bacillus clausii
RxNorm normalized name: BACILLUS CLAUSII
DrugBank: Bacillus clausii (DB16537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus clausii supplementation along with conventional treatment.
Trial: 34233966
Drug: Probiotic and
RxNorm normalized name: Florastor Advanced Probiotic And Digestive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic and egg oral immunotherapy (OIT) administered once daily for 18 months
Trial: 34233966
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered once daily for 18 months
Trial: 33275278
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D
Trial: 33113161
Drug: Hyoscine‐N‐butylbromide 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine‐N‐butylbromide 20 mg (1 mL)
Trial: 33113161
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water (1 mL)
Trial: 33231281
Drug: Ketorolac group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac group (50 mg bupivacaine + 30 mg ketorolac)
Trial: 33231281
Drug: Bupivacaine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine group (50 mg bupivacaine)
Trial: 33827012
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy only
Trial: 33891230
Drug: placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo capsules
Trial: 35470300
Drug: Aggressive Hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive Hydration (vHR) with lactated Ringer's solution (3 mL/kg/h during procedure, 20 ml/kg bolus immediately afterward, then 3 mL/kg/h for another 8 hours)
Trial: 35470300
Drug: High-dose Rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Rectal Indomethacin (100 mg suppository immediately post-ERCP)
Trial: 34258265
Drug: Cytoreductive surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS+HIPEC)
Trial: 33768245
Drug: Levcromakalim (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levcromakalim (0.05 mg/min infusion)
Trial: 33215889
Drug: Low Amplitude
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low Amplitude Seizure Therapy (LAP-ST)
Trial: 33215889
Drug: Standard Right
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Right Unilateral Electroconvulsive Therapy (RUL ECT)
Trial: 34850952
Drug: DMARD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMARD treatment (increased from 17% in 1993-1997 to 52% in 2015-2019)
Trial: 34850952
Drug: DMARD treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMARD treatment
Trial: 36062815
Drug: Anticoagulant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant therapy
Trial: 33498834
Drug: Text messaging
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text messaging and mailed nicotine replacement medication
Trial: 33352008
Drug: PF-06823859 (SAD)
RxNorm normalized name: PF-05089771
DrugBank: PF-05089771 (DB14856)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06823859 (SAD) 30, 100, 300, 900, or 2000 mg
Trial: 38779539
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT)
Trial: 34427687
Drug: Positive psychology
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive psychology intervention for diabetes distress; details on dosage and duration not available.
Trial: 34427687
Drug: Remote protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remote protocol adaptation due to COVID-19; details on dosage and duration not available.
Trial: 36300304
Drug: Nivolumab 240
RxNorm normalized name: nivolumab 240 MG in 24 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 240 mg every 2 weeks for up to 120 days after radical surgery
Trial: 36300304
Drug: Nivolumab 240
RxNorm normalized name: nivolumab 240 MG in 24 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 240 mg every 2 weeks for up to 120 days after radical surgery (in patients with PD-L1 expression level of 1% or more)
Trial: 32926286
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg N and 0 mg Ni)
Trial: 34214683
Drug: AC niosome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC niosome gel
Trial: 34214683
Drug: AC gel
RxNorm normalized name: Zantac GELdose
DrugBank: Actinium (DB12860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC gel
Trial: 34214683
Drug: Triamcinolone gel
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone gel
Trial: 33991432
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy (BT) - 5 sessions including diaphragmatic breathing exercises
Trial: 35332654
Drug: Liraglutide (≤1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (≤1.8 mg/day)
Trial: 33399377
Drug: Ultrasound-guided bilateral
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided bilateral mid-axillary TAP block with 20 ml of bupivacaine 0.25% (Group T)
Trial: 32506695
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with golimumab
Trial: 34483247
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone (8 mg/24 h) administered via Microwick device
Trial: 34483247
Drug: Control (contralateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (contralateral ear without treatment)
Trial: 33704806
Drug: Selgantolimod (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selgantolimod (1.5 mg for 2 weeks or 3 mg for 2 or 4 weeks)
Trial: 38834540
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg)
Trial: 36058913
Drug: Change Club
RxNorm normalized name: Hercules Club Whole
DrugBank: Zanthoxylum clava-herculis whole (DB14353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change Club (CC) intervention
Trial: 34922258
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannula (HFNC) at 20 L/min
Trial: 32602616
Drug: Budesonide (tapering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (tapering doses from 9 to 3 mg for 12 weeks)
Trial: 32307004
Drug: Dexamethasone 0.25
RxNorm normalized name: dexamethasone 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 0.25 mg/kg every 6 hours for a total of four doses, started 6 to 12 hours prior to extubation
Trial: 34625209
Drug: Once‐weekly oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once‐weekly oral practice session
Trial: 34882500
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg once daily bupropion
Trial: 32475050
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy with achieved systolic blood pressure (SBP) measurements
Trial: 34046159
Drug: Ketamine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine administration
Trial: 35496380
Drug: Standard titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard titration for the first 6 days
Trial: 35526164
Drug: Midazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1 mg/kg)
Trial: 33092327
Drug: Pilates exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates exercises (16 sessions, 60 minutes each, twice a week for 8 weeks)
Trial: 32335356
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus curcumin (CUC-1®, 300 mg solution, once per week)
Trial: 35285922
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment group (systolic BP target < 120 mm Hg)
Trial: 35242206
Drug: Rehabilitation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation therapy alone
Trial: 36122531
Drug: Adjunctive perampanel
RxNorm normalized name: Perampanel
DrugBank: Perampanel (DB08883)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjunctive perampanel (≤12 mg/day)
Trial: 34663363
Drug: Betaine (BG,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaine (BG, 2 g/day; n=14)
Trial: 37811711
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics
Trial: 32911733
Drug: Foot exercises
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foot exercises daily for six weeks (Group 1)
Trial: 34197181
Drug: Docetaxel (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (60 mg/m2 once every 3 weeks for three cycles before RT and 20 mg/m2 once weekly during RT)
Trial: 32782729
Drug: Methadone (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (5 mg/ml)
Trial: 32782729
Drug: Tincture of
RxNorm normalized name: Tincture of opium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tincture of Opium (TOP) (10 mg/ml)
Trial: 33954888
Drug: Home hospital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home hospital care (including nurse and physician home visits, intravenous medications, remote monitoring, video communication, and point‐of‐care testing)
Trial: 34254256
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous iron (400 mg/week)
Trial: 34254256
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous iron (100 mg/week)
Trial: 35087753
Drug: Volumetric Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volumetric Modulated Arc Therapy (VMAT)
Trial: 35274356
Drug: Hybrid closed‐loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed‐loop insulin delivery
Trial: 35274356
Drug: Sensor‐augmented pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor‐augmented pump therapy
Trial: 32520991
Drug: l-serine (594
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-serine (594 mg daily) and EPA (149 mg daily)
Trial: 32520991
Drug: l-serine and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-serine and EPA
Trial: 33392636
Drug: Early apixaban
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Early apixaban therapy
Trial: 33276145
Drug: Self-control treatment
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-control treatment group (7-week smartphone-based self-control intervention)
Trial: 33483173
Drug: LTH +
RxNorm normalized name: Leader Eye Health + Lutein Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTH + G advertisements
Trial: 39706874
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus lifestyle intervention
Trial: 37815865
Drug: Intralesional corticosteroid
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional corticosteroid injection
Trial: 35028764
Drug: Low-level light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level light therapy with light-emitting diodes (LED) applied on two acupoints (CV4 and CV6)
Trial: 35028764
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with oral Marvelon, 30 µg of ethinyl estradiol and 150 µg of desogestrel (DSG/EE)
Trial: 33355814
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin injection at anterior and posterior regions (group 2)
Trial: 35786077
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy in the rehab unit
Trial: 32282739
Drug: Research group:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Research group: first bolus of 20% diluted contrast agent (1 ml/kg, upper limit 25 ml) followed by undiluted contrast agent (1 ml/kg, upper limit 25 ml).
Trial: 35095912
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet with 500 mg/kg of Gallic Acid + transportation (TS+GA)
Trial: 33990435
Drug: Catheter-directed cervical
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catheter-directed cervical interlaminar epidural steroid injection with triamcinolone
Trial: 33990435
Drug: Cervical transforaminal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cervical transforaminal steroid injection with dexamethasone
Trial: 37591648
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy
Trial: 39372262
Drug: Topical placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical placebo
Trial: 34607784
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) using Ga Al As laser with a wavelength of 810nm and a power of 100 mW, applied on days 0, 3, 30, and 60 for 18 seconds each time.